Global intravenous iron drugs market is anticipated to grow at a brisk rate in the coming five years. Rising deficiency of iron is leading to surging anemic patients, globally which has led to the growth of intravenous iron drug market. Anemia is prevalent in pregnant women and can be harmful to baby. Keeping in mind the health of mothers and their babies, governments and key players of the market have commenced funding in huge amounts to the healthcare sector. However, government has also imposed strict rules and regulations to limit the use of these drugs as they bring along numerous side-effects with them, which might hinder the growth of the market.

The market of global intravenous iron drugs can be segmented on the basis of application, product, end-user, company and region. The end-use segment is further fragmented into hospitals, clinics and others. Clinics are expected to dominate the market in the year of 2021 as they are the major centers for providing intravenous iron drugs to people.

Based on regional analysis, North America was the dominant region in 2021 as the region has witnessed a rise in the number of anemic patients over the past years. On the other hand, Asia-Pacific is expected to grow at the highest CAGR during the forecast period on account of the rising awareness amongst people regarding chronic diseases such as anemia, etc.

Major players operating in the global intravenous iron drugs market include AMAG pharmaceuticals, Inc., Vifor Pharma Group, Daiichi Sankyo Company, Limited, Sanofi SA, Rockwell Medical Inc., Allergan PLC, Pfizer Inc, Nippon Shinyaku Co., Novartis International AG, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Shield Therapeutics PLC, Merck & Co., Inc. and Biocon Limited. The companies tend to adopt various organic and inorganic strategies to sustain in the market of intravenous iron drugs.

Objective of the Study:

  • To analyze and estimate the market size of global intravenous iron drugs market from 2017 to 2020.
  • To estimate and forecast the market size of global intravenous iron drugs market from 2021 to 2027 and growth rate until 2027.
  • To classify and forecast global intravenous iron drugs market based on application, product, end-user, company and region.
  • To identify dominant region or segment in the global intravenous iron drugs market.
  • To identify drivers and challenges for global intravenous iron drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global intravenous iron drugs market.
  • To conduct pricing analysis for global intravenous iron drugs market.
  • To identify and analyze the profile of leading players operating in global intravenous iron drugs market.
  • To identify key sustainable strategies adopted by market players in global intravenous iron drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global intravenous iron drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Intravenous iron drugs manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to intravenous iron drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume in Units and CAGR for 2017-2021 and 2022E-2027F

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Application
  • Product
  • End User

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Singapore; Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Argentina, Colombia;

Key companies profiled

AMAG pharmaceuticals, Inc., Vifor Pharma Group, Daiichi Sankyo Company, Limited, Sanofi SA, Rockwell Medical Inc., Allergan PLC, Pfizer Inc, Nippon Shinyaku Co., Novartis International AG, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Shield Therapeutics PLC, Merck & Co., Inc. and Biocon Limited.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global intravenous iron drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Intravenous Iron Drugs Market, By Application:
    • Intestinal malabsorption syndromes
    • Inflammatory diseases
    • Gastrectomy/bariatric surgery
    • Anemia
    • Osier-Weber-Rendu disease
    • Angiodysplasia
    • Pregnancy
    • Others
  • Global Intravenous Iron Drugs Market, By Product:
    • Iron dextran
    • Ferric gluconate
    • Iron sucrose
    • Ferric carboxymaltos
    • Iron isomaltoside 100
    • Ferumoxytol
  • Global Intravenous Iron Drugs Market, By End-User:
    • Hospitals
    • Clinics
    • Others
  • Global Intravenous iron drugs Market, By Region:
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Singapore
      • Australia
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Intravenous iron drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global intravenous iron drugs market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customer

5.    Global Intravenous Iron Drugs Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Application (Intestinal malabsorption syndromes, Inflammatory diseases, Gastrectomy/bariatric surgery, Anemia, Osier-Weber-Rendu disease, Angiodysplasia, Pregnancy, Others)

5.2.2.     By Product (Iron dextran, Ferric gluconate, Iron sucrose, Ferric carboxymaltos, Iron isomaltoside 1000, Ferumoxytol)

5.2.3.     By End-User (Hospitals, Clinics, Others)

5.2.4.     By Company (2021)

5.2.5.     By Region

5.3.  Market Attractiveness Index

6.    Asia-Pacific Intravenous Iron Drugs Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Application

6.2.2.     By Product

6.2.3.     By End-User

6.2.4.     By Country

6.3.  Market Attractiveness Index

6.4.  Asia-Pacific: Country Analysis

6.4.1.     China Intravenous Iron Drugs Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Application

6.4.1.2.2.             By Product

6.4.1.2.3.             By End-User

6.4.2.     India Intravenous Iron Drugs Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Application

6.4.2.2.2.             By Product

6.4.2.2.3.             By End-User

6.4.3.     Japan Intravenous Iron Drugs Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Application

6.4.3.2.2.             By Product

6.4.3.2.3.             By End-User

6.4.4.     South Korea Intravenous Iron Drugs Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Application

6.4.4.2.2.             By Product

6.4.4.2.3.             By End-User

6.4.5.     Singapore Intravenous Iron Drugs Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Application

6.4.5.2.2.             By Product

6.4.5.2.3.             By End-User

6.4.6.     Australia Intravenous Iron Drugs Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Application

6.4.6.2.2.             By Product

6.4.6.2.3.             By End-User

7.    Europe Intravenous Iron Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Application

7.2.2.     By Product

7.2.3.     By End-User

7.2.4.     By Country

7.3.  Market Attractiveness Index

7.4.  Europe: Country Analysis

7.4.1.     France Intravenous Iron Drugs Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Application

7.4.1.2.2.             By Product

7.4.1.2.3.             By End-User

7.4.2.     Germany Intravenous Iron Drugs Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Application

7.4.2.2.2.             By Product

7.4.2.2.3.             By End-User

7.4.3.     United Kingdom Intravenous Iron Drugs Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Application

7.4.3.2.2.             By Product

7.4.3.2.3.             By End-User

7.4.4.     Italy Intravenous Iron Drugs Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Application

7.4.4.2.2.             By Product

7.4.4.2.3.             By End-User

8.    North America Intravenous Iron Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Application

8.2.2.     By Product

8.2.3.     By End-User

8.2.4.     By Country

8.3.  Market Attractiveness Index

8.4.  North America: Country Analysis

8.4.1.     United States Intravenous Iron Drugs Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Application

8.4.1.2.2.             By Product

8.4.1.2.3.             By End-User

8.4.2.     Mexico Intravenous Iron Drugs Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Application

8.4.2.2.2.             By Product

8.4.2.2.3.             By End-User

8.4.3.     Canada Intravenous Iron Drugs Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Application

8.4.3.2.2.             By Product

8.4.3.2.3.             By End-User

9.    South America Intravenous Iron Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Application

9.2.2.     By Product

9.2.3.     By End-User

9.2.4.     By Country

9.3.  Market Attractiveness Index

9.4.  South America: Country Analysis

9.4.1.     Brazil Intravenous Iron Drugs Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Application

9.4.1.2.2.             By Product

9.4.1.2.3.             By End-User

9.4.2.     Argentina Intravenous Iron Drugs Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Application

9.4.2.2.2.             By Product

9.4.2.2.3.             By End-User

9.4.3.     Colombia Intravenous Iron Drugs Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Application

9.4.3.2.2.             By Product

9.4.3.2.3.             By End-User

10.  Middle East and Africa Intravenous Iron Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Application

10.2.2.  By Product

10.2.3.  By End-User

10.2.4.  By Country

10.3.              Market Attractiveness Index

10.4.              MEA: Country Analysis

10.4.1.  South Africa Intravenous Iron Drugs Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Application

10.4.1.2.2.           By Product

10.4.1.2.3.           By End-User

10.4.2.  Saudi Arabia Intravenous Iron Drugs Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Application

10.4.2.2.2.           By Product

10.4.2.2.3.           By End-User

10.4.3.  UAE Intravenous Iron Drugs Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Application

10.4.3.2.2.           By Product

10.4.3.2.3.           By End-User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Players Profiled (Leading Companies)

13.2.1.  AMAG pharmaceuticals, Inc.

13.2.2.  Vifor Pharma Group

13.2.3.  Daiichi Sankyo Company, Limited

13.2.4.  Sanofi SA

13.2.5.  Rockwell Medical Inc.

13.2.6.  Allergan PLC

13.2.7.  Pfizer Inc

13.2.8.  Nippon Shinyaku Co.

13.2.9.  Novartis International AG

13.2.10.                Takeda Pharmaceutical Company Limited

13.2.11.                Bausch Health Companies Inc.

13.2.12.                Shield Therapeutics PLC

13.2.13.                Merck & Co., Inc.

13.2.14.                Biocon Limited

14.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com